AI chronic heart failure digital coach market seen growing to $6.64 billion by 2030

The market for artificial intelligence-powered chronic heart failure digital coaches is projected to jump from $1.93 billion in 2025 to $6.64 billion by 2030, as remote monitoring, connected devices and personalized care tools gain traction. North America held the largest share in 2025, while the report points to broader adoption of AI analytics and home-based cardiac monitoring.

Why it matters: - AI-powered digital coaches are becoming a new layer of support for people managing chronic heart failure, a condition that often requires constant monitoring and adherence. - The market growth signals stronger demand for tools that can help clinicians spot complications earlier and keep patients engaged between visits. - The broader shift also reflects how healthcare systems are using AI to move more care into the home and outside traditional clinical settings.

What happened: - The Business Research Company released its Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Global Market Report 2026, with market sizing and forecasts through 2035. - The report says the market will grow from $1.93 billion in 2025 to $2.48 billion in 2026. - The report projects the market will reach $6.64 billion by 2030. - The report cites North America as the largest regional market in 2025.

The details: - The report ties recent growth to rising heart failure incidence, wider adoption of remote patient monitoring, greater healthcare digitization and broader use of connected medical devices. - The forecast period is expected to benefit from AI-powered clinical analytics, personalized care management programs, home-based cardiac monitoring, digital cardiology investment and demand for continuous patient engagement. - The report highlights growing deployment of AI-based cardiac monitoring coaches, integration with wearable heart sensors and expanded use of predictive health analytics. - Remote chronic care platforms and patient self-management tools are also gaining traction. - An AI-powered chronic heart failure digital coach continuously analyzes patient health data to support decision-making, improve treatment adherence and trigger timely interventions. - The report says cardiovascular disease remains a major driver of demand, including coronary heart disease, cerebrovascular disease and other circulatory system disorders. - The report cites CDC data released in October 2024 showing 919,032 U.S. cardiovascular disease deaths in 2023, or about one in three deaths. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel forecasting dashboards, market hotspots infographics and updated graphics and tables. - The company is offering a free sample of the report at the sample report. - The full report is available at the full market report.

Between the lines: - The market outlook suggests AI in cardiology is shifting from experimental monitoring to routine care support. - The strongest growth drivers are not just medical need, but also the spread of devices and platforms that can collect patient data continuously. - The report's emphasis on predictive analytics and self-management tools points to a market built around preventing deterioration, not only reacting to it.

What's next: - The market is expected to keep expanding through 2030 as healthcare providers and patients adopt more connected monitoring and digital coaching tools. - Future competition is likely to center on better analytics, tighter wearable integration and more personalized care workflows. - The report indicates continued opportunity for global adoption beyond North America as digital cardiology platforms scale.